TACR1 and neoplasm: Additionally, CGA-TSHR, EFNA2-EPHA1, FGF17-FGFR2, FGF3-FGFR2, and TAC4-TACR1 were high-scoring tumor-to-stroma signaling interactions in both primary and metastatic lesions.